Sort
39,280 grants matching “leukemia”
Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation
$474,760Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation
$474,760Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2009 · HL
Therapeutic targeting of glutamine metabolism in MDS
$474,750Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2010 · HL
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2011 · HL
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy
$474,745Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
$474,721Nelson J. Chao · Duke University · UG3 · FY2018 · TR
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$474,673Stephen S Hecht · University Of Minnesota · R37 · FY2007 · CA
ONCOGENESIS AND MYELOID TRANSCRIPTION FACTORS IN AML
$474,639Daniel G Tenen · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Resequencing
$474,630Seth Daniel Crosby · Washington University · P01 · FY2008 · CA
Transduction of Schistosoma mansoni by pseudotyped retrovirus
$474,547Paul J Brindley · George Washington University · R01 · FY2009 · AI
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$474,416Wafik S El-Deiry · Brown University · R01 · FY2023 · CA
Understanding Richter's Transformation in the targeted therapies era
$474,404Rosa Lapalombella · Ohio State University · R01 · FY2021 · CA
Understanding Richter's Transformation in the targeted therapies era
$474,404Rosa Lapalombella · Ohio State University · R01 · FY2020 · CA
MOLECULAR STUDIES OF DRUG RESISTANCE IN CHRONIC LYMPHOCY
$474,393Ohio State University · R01 · FY2002 · CA
Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas
$474,337Adam Lyon Green · University Of Colorado Denver · R01 · FY2024 · NS
NCTN Lead Academic Participating Sites Application
$474,318Lisa A Carey · Univ Of North Carolina Chapel Hill · U10 · FY2016 · CA
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$474,252Maurizio Pellecchia · University Of California Riverside · R01 · FY2016 · CA
CD19 Directed CAR Therapy
$474,213Carl H. June · University Of Pennsylvania · R01 · FY2013 · CA
Semiparametric Analysis of Censored Data in Current Medical Studies
$474,170Danyu Lin · Univ Of North Carolina Chapel Hill · R01 · FY2015 · GM
Role of IL-17 receptor A in aging bone remodeling
$474,110Hicham M Drissi · Emory University · R01 · FY2024 · AG
The role of innate immunity in downregulation of the airway antioxidant response during paramyxovirus infection
$474,000Antonella Casola · University Of Texas Med Br Galveston · P01 · FY2022 · AI
The role of innate immunity in downregulation of the airway antioxidant response during paramyxovirus infection
$474,000Antonella Casola · University Of Texas Med Br Galveston · P01 · FY2020 · AI
The role of innate immunity in downregulation of the airway antioxidant response during paramyxovirus infection
$474,000Antonella Casola · University Of Texas Med Br Galveston · P01 · FY2021 · AI